Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: a population-based

Anders Holmgren1, Johan Ljungberg2, Johan Hultdin3

  • 1Public Health and Clinical Medicine, Cardiac Surgery, Umeå University, Umeå, Sweden.

Open Heart
|October 14, 2020
PubMed

Insights

High-sensitivity troponin T (hs-TnT) is linked to a higher risk and earlier need for aortic stenosis (AS) surgery. Hs-TnT also correlates with increased myocardial mass, suggesting its potential as a biomarker for intervention timing.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Aortic Stenosis

Background:

  • Aortic stenosis (AS) is a significant cardiovascular condition.
  • Prognostic markers are crucial for managing AS patients.
  • High-sensitivity troponin T (hs-TnT) and high-sensitivity C-reactive protein (hs-CRP) are potential biomarkers.

Purpose of the Study:

  • To investigate the association of hs-TnT and hs-CRP with myocardial mass in AS patients.
  • To evaluate the predictive value of hs-TnT and hs-CRP for future AS surgery.
  • To determine if these biomarkers can indicate the need for intervention.

Main Methods:

  • Retrospective analysis of 336 AS patients who underwent surgery.
  • Assessment of preoperative myocardial mass and coronary artery disease (CAD).
  • Measurement of hs-TnT and hs-CRP from stored plasma samples.
  • Conditional logistic regression and survival analyses (Kaplan-Meier, Cox regression).

Main Results:

  • Hs-TnT was independently associated with a higher risk of AS surgery (OR 1.24, 95% CI 1.06-1.44).
  • Elevated hs-TnT levels correlated with a shorter time to surgery and increased myocardial mass.
  • Hs-CRP showed no significant association with AS surgery risk, time to surgery, or myocardial mass.

Conclusions:

  • Hs-TnT, but not hs-CRP, predicts increased risk and earlier need for AS surgery.
  • Hs-TnT's association with myocardial mass suggests its utility as a biomarker for intervention timing in AS.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
117
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
631
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
111
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
395
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
259
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
145